Molecular pathology of thyroid cancer: diagnostic and clinical implications.

Molecular pathology of thyroid cancer: diagnostic and clinical implications.
复制标题

DOI:
10.1016/j.beem.2008.09.017
复制
发表时间:
2008-12
影响因子:
7.4
通讯作者:
Mitsiades, Nicholas
Mitsiades, Nicholas
中科院分区:
医学2区
文献类型:
--
作者:
Fagin, James A.;Mitsiades, Nicholas

文献摘要

参考文献

被引文献

相似文献

现在人们对甲状腺癌发生和进展中涉及的关键致癌事件有了相当好的了解。其中许多是某些肿瘤类型的特征,它们的存在传达了诊断和预后信息。目前尚不清楚这些信息将如何应用于临床实践。基于临床前证据,编码某些激酶的基因突变也可能预测对特定酪氨酸激酶抑制剂的反应,尽管这尚未在临床试验中系统地探索。
There is now a reasonably good understanding of the key oncogenic events involved in the initiation and progression of thyroid cancer. Many of these are characteristic of certain tumor types, and their presence conveys diagnostic and prognostic information. It is not yet clear how this information will be applied to clinical practice. Based on preclinical evidence, mutations of genes encoding certain kinases may also predict response to specific tyrosine kinase inhibitors, although this has not yet been explored systematically in clinical trials.
DOI: 10.1093/jnci/95.8.625
发表时间: 2003-04-16
期刊: JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子: --
作者:
Cohen, J;Xing, MZ;Sidransky, D
通讯作者: Sidransky, D
DOI: 10.1097/01.pas.0000176432.73455.1b
发表时间: 2006-02-01
影响因子: 5.6
作者:
Adeniran, AJ;Zhu, ZW;Nikiforov, YE
通讯作者: Nikiforov, YE
DOI: 10.1016/s0140-6736(00)04817-0
发表时间: 2001-05-26
期刊: LANCET
影响因子: 168.9
作者:
Bartolazzi, A;Gasbarri, A;Larsson, O
通讯作者: Larsson, O
DOI: 10.1210/jc.2007-1571
发表时间: 2008-04-01
影响因子: 5.8
作者:
Durand, Stephanie;Ferraro-Peyret, Carole;Rousset, Bernard
通讯作者: Rousset, Bernard
DOI: 10.1172/jci116385
发表时间: 1993-04-01
影响因子: 15.9
作者:
DONGHI, R;LONGONI, A;PIEROTTI, MA
通讯作者: PIEROTTI, MA